AUDITED STANDALONE FINANCIALS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED ON 31-03-2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company reported audited FY25 revenue from operations of ₹16.22 lakhs, down about 41% from ₹27.68 lakhs in FY24. Net loss for FY25 widened to ₹72.65 lakhs versus ₹68.12 lakhs in the prior year, with Q4 FY25 loss at ₹17.46 lakhs. The balance sheet shows severely negative other equity of ₹(11,468.12) lakhs, meaning accumulated losses vastly exceed share capital, while total borrowings stand at roughly ₹3,690 lakhs. Operating cash flow was negative at ₹(69.40) lakhs. The going-concern assumption is supported only through a promoter comfort letter. The auditor issued an unqualified opinion but drew attention to outstanding PF dues of ₹16.38 lakhs spanning 2013-14 to 2023-24, and disclosed pending disputes including excise duty of ~₹8.52 crore at CESTAT Hyderabad and customs duty of ~₹1.04 crore at CESTAT Bangalore.
Negative for shareholders — the company is loss-making with a deeply eroded net worth, declining top line, and operational cash burn. Reliance on a promoter comfort letter to sustain going-concern status and pending large tax/excise disputes are material risk factors likely to weigh on the stock.